A liaison-clinical pathway for patients with stageI to III gastric cancer after curative operation has been introduced and managed in our hospital from July 2009. We made two kinds of liaison-clinical pathway in the presence or absence of postoperative adjuvant therapy. The duration of follow-up was 5 years in proportion to the Guidelines for Diagnosis and Treatment of Carcinoma of the Stomach. We held a briefing session for practicing physicians involved after liaison-clinical pathway making, conducted a questionnaire, and judged whether induction was possible. The liaison-clinical pathway consists of a chart for practicing physicians, leaflets with checklists for the patients, and other documents. We began to use them in July, 2009, and involved patients are 11 to date. Because postoperative treatment planning became clear by using the liaison-clinical pathway, we were able to relieve the anxiety of patients with cancer, and it seemed that it was easy to facilitate to perform cancer cooperation by the practicing physicians. For the introduction and management of this pathway, a thorough explanation to the patients with gastric cancer and good communication is required with the practicing physicians in cooperation with the coordinator.
Download full-text PDF |
Source |
---|
Gan To Kagaku Ryoho
October 2015
Dept. of Surgery, Osaka Saiseikai Izuo Hospital.
We retrospectively examined the feasibility and outcome of S-1 adjuvant chemotherapy for 18 patients with gastric cancer treated based on the liaison-clinical pathway (liaison group), and compared them with those of 26 patients treated before the induction of the liaison-clinical pathway (non-liaison group). The persistent rate of S-1 adjuvant chemotherapy for one year except for recurrence, the relative performance (RP) value of cases who had received S-1 for one year, and Grade 3/4 adverse events in non-liaison group/liaison group, were 88.5/87.
View Article and Find Full Text PDFKekkaku
December 2012
National Hospital Organization Higashihiroshima Medical Center, 513 Jike, Saijo-cho, Higashihiroshima-shi, Hiroshima 739-0041 Japan.
As the incidence of active tuberculosis in Japan declines and the healthcare environment changes, restructuring of the medical care system for tuberculosis is required. According to a questionnaire survey in Hiroshima Prefecture, experiences in tuberculosis (TB) care and knowledge, such as standard treatment and DOT, is insufficient in the local medical institutions designated for tuberculosis care. Regional coordination between the tuberculosis hospital and the regional private practitioners will be one of the important issues in proper TB care.
View Article and Find Full Text PDFGan To Kagaku Ryoho
August 2010
Dept. of Breast-Surgical Oncology, Osaka City General Hospital.
Gan To Kagaku Ryoho
June 2010
Department of Gastrointestinal Surgery, Osaka City General Hospital.
A liaison-clinical pathway for patients with stageI to III gastric cancer after curative operation has been introduced and managed in our hospital from July 2009. We made two kinds of liaison-clinical pathway in the presence or absence of postoperative adjuvant therapy. The duration of follow-up was 5 years in proportion to the Guidelines for Diagnosis and Treatment of Carcinoma of the Stomach.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!